BIONTECH
Dead / Cancelled — Cancelled — Section 8 (as of 22 Nov 2019)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85707820
- Registration number
- 4320763
- Mark type
- Word mark
- Filed
- 20 Aug 2012
- Published for opposition
- 29 Jan 2013
- Registered
- 16 Apr 2013
- Attorney of record
- Kathleen T. Petrich
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases
- Class 010 — Medical apparatus: Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; Medical diagnostic devices for analysis of body fluids and biopsies for patient stratification
- Class 016 — Paper goods and printed matter: Pharmaceutical information leaflets; Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters for providing medical, pharmaceutical and scientific research information
- Class 042 — Scientific and technological services: Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
Owner
- BioNTech AG, Mainz, DE
- BioNTech AG, Mainz, DE
- BioNTech AG, Mainz, DE
Prior registrations
Prosecution history
- 22 Nov 2019 — CANCELLED SEC. 8 (6-YR)
- 16 Apr 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jan 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2014 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2014 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Nov 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Apr 2013 — REGISTERED-PRINCIPAL REGISTER
- 29 Jan 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jan 2013 — PUBLISHED FOR OPPOSITION
- 09 Jan 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Dec 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Dec 2012 — ASSIGNED TO EXAMINER
- 28 Aug 2012 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Aug 2012 — NEW APPLICATION ENTERED